These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 28774544)

  • 21. Ocular surface neoplasia masquerading as chronic blepharoconjunctivitis.
    Akpek EK; Polcharoen W; Chan R; Foster CS
    Cornea; 1999 May; 18(3):282-8. PubMed ID: 10336029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ocular Surface Squamous Neoplasia Managed With Primary Interferon α2b: A Comparative Analysis of 212 Tumors in Smokers Versus Nonsmokers.
    Shields CL; Paulose SA; Yaghy A; Dalvin LA; Constantinescu AB; Lally SE; Shields JA
    Cornea; 2021 Nov; 40(11):1387-1394. PubMed ID: 33273189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Topical treatment with mitomycin C in considerably raised conjunctival intraepithelial neoplasia].
    Rodríguez-Pérez C; Del Campo Z; Wolley-Dod C; Gris O
    Arch Soc Esp Oftalmol; 2002 Dec; 77(12):685-8. PubMed ID: 12471516
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of recurrent corneal and conjunctival intraepithelial neoplasia with topical interferon alfa 2b.
    Boehm MD; Huang AJ
    Ophthalmology; 2004 Sep; 111(9):1755-61. PubMed ID: 15350333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized controlled trial of topical mitomycin C for ocular surface squamous neoplasia: early resolution.
    Hirst LW
    Ophthalmology; 2007 May; 114(5):976-82. PubMed ID: 17241666
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ocular Surface Squamous Neoplasia: From Blue Skies to Blue Dyes--We Still Need Our Ophthalmic Pathologists.
    Shields CL; Shields JA
    JAMA Ophthalmol; 2015 Nov; 133(11):1321-2. PubMed ID: 26378883
    [No Abstract]   [Full Text] [Related]  

  • 27. Subconjunctival/perilesional recombinant interferon α2b for ocular surface squamous neoplasia: a 10-year review.
    Karp CL; Galor A; Chhabra S; Barnes SD; Alfonso EC
    Ophthalmology; 2010 Dec; 117(12):2241-6. PubMed ID: 20619462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Photodynamic therapy for conjunctival ocular surface squamous neoplasia.
    Cekiç O; Bardak Y; Kapucuoğlu N
    J Ocul Pharmacol Ther; 2011 Apr; 27(2):205-7. PubMed ID: 21417754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of HSP90 Expression Is Valuable in the Differential Diagnosis of Ocular Surface Squamous Lesions.
    Zoroquiain P; Faingold D; Algahmdi S; Vila N; Logan P; Sanft DM; Toledo Dias AB; Aldrees S; Bravo-Filho V; Burnier J; Burnier MN
    Am J Clin Pathol; 2016 Mar; 145(3):385-92. PubMed ID: 27124921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of 1% toluidine blue eye drops in the diagnosis of ocular surface squamous neoplasia.
    Romero IL; Barros Jde N; Martins MC; Ballalai PL
    Cornea; 2013 Jan; 32(1):36-9. PubMed ID: 22525782
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of diffuse ocular surface squamous neoplasia: efficacy and complications of topical chemotherapy.
    Rudkin AK; Dempster L; Muecke JS
    Clin Exp Ophthalmol; 2015; 43(1):20-5. PubMed ID: 24995542
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term outcomes after adjunctive topical 5-flurouracil or mitomycin C for the treatment of surgically excised, localized ocular surface squamous neoplasia.
    Bahrami B; Greenwell T; Muecke JS
    Clin Exp Ophthalmol; 2014; 42(4):317-22. PubMed ID: 23927413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ocular surface carcinoma.
    Mark HH
    Conn Med; 2006 Feb; 70(2):73-5. PubMed ID: 16768057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of topical bevacizumab for conjunctival intraepithelial neoplasia.
    Özcan AA; Çiloğlu E; Esen E; Şimdivar GH
    Cornea; 2014 Nov; 33(11):1205-9. PubMed ID: 25014150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intraepithelial neoplasia of the bulbar conjunctiva clinically presenting as diffuse papillomatosis.
    Khalil MK; Pierson RB; Mihalovits H; Bell RA; Lorenzetti DW
    Can J Ophthalmol; 1993 Oct; 28(6):287-90. PubMed ID: 8299055
    [No Abstract]   [Full Text] [Related]  

  • 36. Cytologic and DNA cytometric diagnosis and therapy monitoring of squamous cell carcinoma in situ and malignant melanoma of the cornea and conjunctiva.
    Nadjari B; Kersten A; Ross B; Motherby H; Krallmann R; Sundmacher R; Böcking A
    Anal Quant Cytol Histol; 1999 Oct; 21(5):387-96. PubMed ID: 10560521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Squamous Cell Neoplasm of the Ocular Surface in a Patient With Psoriasis Treated With Tumor Necrosis Factor-Alpha Inhibitors.
    Lezcano Carduz VP; Mingo Botín D; Durán Poveda SP
    Cornea; 2015 Jul; 34(7):833-4. PubMed ID: 26010941
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of combination therapy of topical mitomycin C and cyclosporine a as an adjunct to surgery for corneal and conjunctival intraepithelial neoplasia and invasive squamous cell carcinoma.
    Sugandhi P; George RE
    Cornea; 2011 Apr; 30(4):486; author reply 486-7. PubMed ID: 21107255
    [No Abstract]   [Full Text] [Related]  

  • 39. Ocular surface toxicity associated with topical interferon alpha-2b.
    Aldave AJ; Nguyen A
    Br J Ophthalmol; 2007 Aug; 91(8):1087-8. PubMed ID: 17638822
    [No Abstract]   [Full Text] [Related]  

  • 40. Identification of ocular surface squamous neoplasia by in vivo staining with methylene blue.
    Steffen J; Rice J; Lecuona K; Carrara H
    Br J Ophthalmol; 2014 Jan; 98(1):13-5. PubMed ID: 24158840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.